Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - ArthroCare Corporation (NasdaqNM:ARTC)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Options | Financials | Reports
Location
595 North Pastoria Avenue
Sunnyvale, CA 94086
Phone: (408) 736-0224
Fax: (408) 736-0226
Email: investor-relations@arthrocare.com
Employees (last reported count): 272
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Medical Equipment & Supplies
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Index Membership
 ·S&P 600 SmallCap
Ownership
·Insider and 5%+ Owners: 72%
·Over the last 6 months:
 · 18 insider sells; 176.0K shares
  (1.1% of insider shares)
·Institutional: 95% (340% of float)
(216 institutions)
·Net Inst. Buying: 707.0K shares (+3.20%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
ArthroCare Corporation is a medical device company that develops, manufactures and markets products based on its patented Coblation technology. The Company's products allow surgeons to operate with increased precision and accuracy, limiting damage to surrounding tissue thereby potentially reducing pain and speeding recovery for the patient. Coblation technology is applicable across many soft-tissue surgical markets. The Company's systems are used to perform many types of arthroscopic surgery. The Company's strategy includes applying its patented Coblation technology to a broad range of soft-tissue surgical markets, including arthroscopy, cosmetic surgery, ear, nose and throat (ENT), surgery, spinal surgery, neuro surgery, general surgery and various cardiology applications.
More from Market Guide: Expanded Business Description

Financial Summary
ARTC develops, manufactures and markets medical devices based on a patented Coblation technology; the Co.'s products are used in arthroscopic and orthopedic procedures. For the six months ended 6/30/01, revenues rose 22% to $42.7 million. Net income before acct. change fell 26% to $5.2 million. Results reflect demand for new disposable device models, higher list prices, and $3.2 million in previously unrecognized license fees, offset by increased staffing and related expenditures.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

Michael Baker, 42
Pres, CEO
$468K$5.7M
John Raffle, 32
Managing Director, Corp. Devel. and Legal Affairs
--  --  
Christine Hanni, 40
VP - Fin. and CFO
187K827K
John Tighe, 40
VP, Worldwide Sales and Marketing
196K1.6M
Robert Hagan, 55
VP - Manufacturing
226K--  
Dollar amounts are as of 29-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:ARTCAs of 31-Aug-2001
Price and Volume
52-Week Low
on 22-Mar-2001
$11.875
Recent Price$29.90 
52-Week High
on 1-Sep-2000
$45.063
Beta0.96 
Daily Volume (3-month avg)323.8K
Daily Volume (10-day avg)293.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change-31.9%
52-Week Change
relative to S&P500
-8.7%
Share-Related Items
Market Capitalization$673.9M
Shares Outstanding22.5M
Float6.30M
Dividends & Splits
Annual Dividendnone 
Last Split: 2 for 1 on 5-July-2000
Per-Share Data
Book Value (mrq)$5.87 
Earnings (ttm)$0.59 
Earnings (mrq)$0.14 
Sales (ttm)$3.25 
Cash (mrq)$3.44 
Valuation Ratios
Price/Book (mrq)5.09 
Price/Earnings (ttm)50.51 
Price/Sales (ttm)9.21 
Income Statements
Sales (ttm)$75.7M
EBITDA (ttm)$13.6M
Income available to common (ttm)$14.0M
Profitability
Profit Margin (ttm)18.5%
Operating Margin (ttm)10.8%
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)10.25%
Return on Equity (ttm)11.32%
Financial Strength
Current Ratio (mrq)11.20 
Debt/Equity (mrq)0 
Total Cash (mrq)$77.5M
Short Interest
As of 8-Aug-2001
Shares Short5.20M
Percent of Float82.5%
Shares Short
(Prior Month)
5.88M
Short Ratio11.84 
Daily Volume439.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.